{
    "timestamp": "Sep 16, 2025 5:13 PM EST",
    "stats": {
        "input_words": 194486,
        "output_words": 1149,
        "filings_processed": 15
    },
    "filings": [
        {
            "company_name": "Medtronic",
            "stock": "MDT",
            "wiki_url": "https://en.wikipedia.org/wiki/Medtronic",
            "change_percent": 0,
            "price": 93.48,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T16:41:16-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1613103/000119312525205061/0001193125-25-205061-index.htm",
            "accession_number": "0001193125-25-205061",
            "summary_points": [
                "1. Medtronic plc issued \u20ac1,500,000,000 of senior notes due 2030 and 2045 on September 15, 2025, to repay existing debt.",
                "2.  Medtronic Luxco redeemed all \u20ac500,000,000 of its outstanding 2.625% Senior Notes due 2025 on September 29, 2025.",
                "3. The offering and redemption were reflected in Medtronic plc's fiscal year 2026 adjusted earnings per share guidance, which was reiterated on August 19, 2025."
            ]
        },
        {
            "company_name": "American Tower",
            "stock": "AMT",
            "wiki_url": "https://en.wikipedia.org/wiki/American_Tower",
            "change_percent": 0,
            "price": 192.49,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T16:15:40-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1053507/000119312525205004/0001193125-25-205004-index.htm",
            "accession_number": "0001193125-25-205004",
            "summary_points": [
                "1. On September 16, 2025, American Tower Corporation completed a registered public offering of $575 million in senior unsecured notes, generating net proceeds of approximately $587.8 million after expenses.",
                "2. The offering included $200 million of 4.900% senior unsecured notes due 2030 and $375 million of 5.350% senior unsecured notes due 2035, increasing the total outstanding amount of these notes to $850 million and $700 million respectively.",
                "3.  The net proceeds will be used to repay existing debt under a $4 billion revolving credit facility and for general corporate purposes."
            ]
        },
        {
            "company_name": "Dollar Tree",
            "stock": "DLTR",
            "wiki_url": "https://en.wikipedia.org/wiki/Dollar_Tree",
            "change_percent": 0,
            "price": 97.23,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T16:01:58-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/935703/000093570325000067/0000935703-25-000067-index.htm",
            "accession_number": "0000935703-25-000067",
            "summary_points": [
                "1. Dollar Tree will unveil a refreshed long-term strategy and financial outlook for its Dollar Tree business on October 15, 2025.",
                "2.  This presentation will be available on the company's investor relations website after the event."
            ]
        },
        {
            "company_name": "Workday, Inc.",
            "stock": "WDAY",
            "wiki_url": "https://en.wikipedia.org/wiki/Workday,_Inc.",
            "change_percent": -0.24,
            "price": 222.83,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T09:08:45-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1327811/000132781125000187/0001327811-25-000187-index.htm",
            "accession_number": "0001327811-25-000187",
            "summary_points": [
                "1. Workday, Inc. has agreed to acquire Sana Labs AB for approximately $1.1 billion, a deal expected to close in the fourth quarter of Workday's fiscal year 2026 (ending January 31, 2026).",
                "2. Sana's AI-powered tools have already served over one million users, and Workday anticipates significant productivity gains for its 75 million users following the acquisition.",
                "3.  The acquisition includes substantial risks, including the possibility of the deal not closing, failure to achieve expected benefits, negative effects on Workday's operations or share price, and unanticipated expenses."
            ]
        },
        {
            "company_name": "DuPont",
            "stock": "DD",
            "wiki_url": "https://en.wikipedia.org/wiki/DuPont",
            "change_percent": -0.2,
            "price": 77.14,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T08:58:23-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1666700/000119312525204406/0001193125-25-204406-index.htm",
            "accession_number": "0001193125-25-204406",
            "summary_points": [
                "1. DuPont amended its exchange offers for outstanding notes due 2028, 2038, and 2048, ensuring all tendering eligible holders receive total consideration regardless of tender date (as of September 16th, 2025).",
                "2.  The withdrawal deadline for the 2038 and 2048 notes was extended to September 17th, 2025, while the 2028 notes withdrawal deadline passed on September 15th, 2025.",
                "3. If DuPont doesn't receive sufficient consents for the 2038 and 2048 notes amendments, it will waive the minimum tender condition and accept up to a maximum of $400,000,000 and $860,000,000 in principal amount, respectively, subject to proration."
            ]
        },
        {
            "company_name": "Ralph Lauren Corporation",
            "stock": "RL",
            "wiki_url": "https://en.wikipedia.org/wiki/Ralph_Lauren_Corporation",
            "change_percent": 0,
            "price": 315.83,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T08:11:46-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1037038/000095014225002436/0000950142-25-002436-index.htm",
            "accession_number": "0000950142-25-002436",
            "summary_points": [
                "1. Ralph Lauren Corporation announced a new three-year financial outlook (from Fiscal 2025 through Fiscal 2028) projecting mid-single-digit revenue growth and operating profit growth exceeding revenue growth in constant currency.",
                "2.  The company plans to return at least $2 billion in excess free cash flow to shareholders cumulatively through Fiscal 2028 via dividends and share repurchases.",
                "3. Ralph Lauren's long-term financial outlook acknowledges potential risks from geopolitical factors (including the Russia-Ukraine and Israel-Hamas wars), inflationary pressures, supply chain disruptions, and consumer spending headwinds."
            ]
        },
        {
            "company_name": "Charles River Laboratories",
            "stock": "CRL",
            "wiki_url": "https://en.wikipedia.org/wiki/Charles_River_Laboratories",
            "change_percent": 0,
            "price": 152.38,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T07:10:48-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1100682/000095010325011676/0000950103-25-011676-index.htm",
            "accession_number": "0000950103-25-011676",
            "summary_points": [
                "1. Flavia H. Pease resigned as CFO of Charles River Laboratories International, Inc. effective September 29, 2025, to pursue another opportunity; her resignation was not due to disagreements with the company.",
                "2. Michael G. Knell was appointed interim CFO, effective September 29, 2025, until a permanent replacement is found.",
                "3.  As of September 16, 2025, Charles River Laboratories reaffirmed its 2025 financial guidance for revenue and non-GAAP earnings per share."
            ]
        },
        {
            "company_name": "Insulet Corporation",
            "stock": "PODD",
            "wiki_url": "https://en.wikipedia.org/wiki/Dexcom",
            "change_percent": 0,
            "price": 340.43,
            "filing_type": "8-K",
            "filing_time": "2025-09-16T07:05:56-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1145197/000119312525204276/0001193125-25-204276-index.htm",
            "accession_number": "0001193125-25-204276",
            "summary_points": [
                "1. On September 11, 2025, Insulet Corp appointed Flavia Pease as Executive Vice President and Chief Financial Officer, effective September 30, 2025, succeeding Ana M. Chadwick, who will become a senior advisor.",
                "2.  Ms. Pease's compensation package includes a prorated 2025 equity award with a target grant date fair value of $762,500, an employment inducement award valued at $3,000,000, and a $1,325,000 cash sign-on award.",
                "3. Insulet Corp expects to exceed its previously issued third-quarter 2025 total revenue growth guidance, driven by strong new customer acquisition in US and international markets; further details will be provided on November 6, 2025."
            ]
        },
        {
            "company_name": "Dayforce",
            "stock": "DAY",
            "wiki_url": "https://en.wikipedia.org/wiki/Dayforce",
            "change_percent": 0,
            "price": 68.93,
            "filing_type": "8-K",
            "filing_time": "2025-09-15T20:02:04-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1725057/000172505725000125/0001725057-25-000125-index.htm",
            "accession_number": "0001725057-25-000125",
            "summary_points": [
                "1. Dayforce, Inc. transferred its defined benefit pension obligations to Nationwide Life & Annuity Insurance Company and Nationwide Life Insurance Company on September 11, 2025, covering approximately 6,200 participants and beneficiaries.",
                "2. This pension obligation transfer is expected to result in a one-time non-cash pre-tax pension settlement charge of approximately $170 million to $190 million in the third quarter of 2025.",
                "3.  The company will make a cash contribution of approximately $7 million to fund the purchase of the group annuity contract."
            ]
        },
        {
            "company_name": "Dexcom",
            "stock": "DXCM",
            "wiki_url": "https://en.wikipedia.org/wiki/Dexcom",
            "change_percent": 0,
            "price": 75.55,
            "filing_type": "8-K",
            "filing_time": "2025-09-15T19:30:47-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1093557/000109355725000257/0001093557-25-000257-index.htm",
            "accession_number": "0001093557-25-000257",
            "summary_points": [
                "1. On September 14, 2025, Dexcom's CEO, Kevin R. Sayer, took a temporary medical leave of absence, resulting in the appointment of Jacob S. Leach as interim CEO and Mark Foletta as interim chairman.",
                "2.  No additional compensation will be provided to Leach and Foletta for their interim roles.",
                "3.  The SEC filing does not specify the duration of Sayer's leave, creating uncertainty regarding the company's leadership and potential future impacts."
            ]
        },
        {
            "company_name": "Steel Dynamics",
            "stock": "STLD",
            "wiki_url": "https://en.wikipedia.org/wiki/Steel_Dynamics",
            "change_percent": 0,
            "price": 131.57,
            "filing_type": "8-K",
            "filing_time": "2025-09-15T16:54:40-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1022671/000110465925090047/0001104659-25-090047-index.htm",
            "accession_number": "0001104659-25-090047",
            "summary_points": [
                "1. Steel Dynamics, Inc. issued third-quarter 2025 earnings guidance on September 15, 2025, projecting earnings between $2.60 and $2.64 per diluted share, a significant increase from the $2.01 reported in the second quarter of 2025 and the $2.05 reported in the same quarter of 2024.",
                "2.  The company repurchased $185 million (1%) of its common stock during the third quarter of 2025.",
                "3.  Increased demand for steel is anticipated due to domestic manufacturing investments, onshoring initiatives, and the U.S. infrastructure program."
            ]
        },
        {
            "company_name": "Home Depot (The)",
            "stock": "HD",
            "wiki_url": "https://en.wikipedia.org/wiki/Home_Depot",
            "change_percent": 0,
            "price": 422.86,
            "filing_type": "8-K",
            "filing_time": "2025-09-15T16:24:49-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/354950/000110465925090021/0001104659-25-090021-index.htm",
            "accession_number": "0001104659-25-090021",
            "summary_points": [
                "1. On September 15, 2025, Home Depot, Inc. completed a public offering of $2 billion in notes due between 2028 and 2035.",
                "2.  The offering consisted of $500,000,000 of 3.750% Notes due September 15, 2028; $500,000,000 of 3.950% Notes due September 15, 2030; and $1,000,000,000 of 4.650% Notes due September 15, 2035.",
                "3. The notes were issued under an Indenture dated May 4, 2005, with The Bank of New York Mellon Trust Company, N.A. as trustee."
            ]
        },
        {
            "company_name": "Crown Castle",
            "stock": "CCI",
            "wiki_url": "https://en.wikipedia.org/wiki/Crown_Castle",
            "change_percent": 0,
            "price": 93.58,
            "filing_type": "8-K",
            "filing_time": "2025-09-15T16:22:08-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1051470/000105147025000176/0001051470-25-000176-index.htm",
            "accession_number": "0001051470-25-000176",
            "summary_points": [
                "1. On September 15, 2025, Crown Castle Inc. appointed Christian H. Hillabrant as President and Chief Executive Officer and also appointed him to the Board of Directors, expanding the board to 10 members.",
                "2.  No related party transactions involving Mr. Hillabrant were reported.",
                "3. There are no material plans, contracts, or arrangements related to Mr. Hillabrant's appointment to the Board, or any grants or awards connected to it."
            ]
        },
        {
            "company_name": "Chipotle Mexican Grill",
            "stock": "CMG",
            "wiki_url": "https://en.wikipedia.org/wiki/Chipotle_Mexican_Grill",
            "change_percent": 0,
            "price": 38.57,
            "filing_type": "8-K",
            "filing_time": "2025-09-15T16:16:23-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1058090/000105809025000075/0001058090-25-000075-index.htm",
            "accession_number": "0001058090-25-000075",
            "summary_points": [
                "1. On September 15, 2025, Chipotle Mexican Grill, Inc. announced a $500 million increase to its existing share repurchase program, bringing the total authorized amount to approximately $750 million.",
                "2.  This $500 million authorization is an increase from a previously unspecified amount in the share repurchase program;  the filing states that $750 million remains authorized as of September 15, 2025.",
                "3. There is no expiration date for the share repurchase program, and Chipotle may modify, suspend, or discontinue it at any time."
            ]
        },
        {
            "company_name": "Elevance Health",
            "stock": "ELV",
            "wiki_url": "https://en.wikipedia.org/wiki/Elevance_Health",
            "change_percent": 0,
            "price": 306.91,
            "filing_type": "8-K",
            "filing_time": "2025-09-15T16:05:10-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1156039/000119312525203542/0001193125-25-203542-index.htm",
            "accession_number": "0001193125-25-203542",
            "summary_points": [
                "1. Elevance Health, Inc. closed a $3 billion notes offering on September 15, 2025, receiving approximately $2.9727 billion in proceeds after expenses.",
                "2.  The net proceeds will be used to repay existing debt ($900 million) with the remainder allocated to working capital and general corporate purposes, including acquisitions and share repurchases.",
                "3.  The Notes have optional redemption provisions allowing Elevance Health to redeem the notes at a make-whole call price (calculated using the Treasury Rate plus a basis point spread) before specified dates and at par thereafter."
            ]
        }
    ]
}